| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,884 | $9.65 | $18,189.45 | -5.9% | -45.8% | +113.9% | |
| May 1, 2023 | Stefani Wolff65 | EVP and COO | Sale+OE | 342 | $9.88 | $3,377.69 | -5.3% | -1.9% | +21.4% | |
| May 1, 2023 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 721 | $9.88 | $7,120.81 | -0.9% | -1.9% | +21.4% | |
| May 1, 2023 | Christine Ring75 | General Counsel | Sale+OE | 682 | $9.88 | $6,735.64 | -6.4% | -1.9% | +21.4% | |
| May 1, 2023 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,136 | $9.88 | $11,219.48 | -4.1% | -1.9% | +21.4% | |
| Jan 30, 2023 | Stefani Wolff65 | EVP and COO | Sale+OE | 424 | $11.78 | $4,994.55 | -9.7% | -16.6% | -32.7% | |
| Jan 30, 2023 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 924 | $11.78 | $10,884.35 | -1.2% | -16.6% | -32.7% | |
| Jan 30, 2023 | Christine Ring75 | General Counsel | Sale+OE | 848 | $11.78 | $9,989.10 | -10.5% | -16.6% | -32.7% | |
| Jan 30, 2023 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,412 | $11.78 | $16,632.80 | -5.8% | -16.6% | -32.7% | |
| Oct 31, 2022 | Stefani Wolff65 | EVP and COO | Sale+OE | 350 | $12.88 | $4,508.18 | -9.3% | -6.8% | -56.1% |